nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A5—ulcerative colitis	0.456	1	CbGaD
Amphetamine—MAOB—Nicotine—ulcerative colitis	0.121	0.303	CbGbCtD
Amphetamine—SLC22A3—Nicotine—ulcerative colitis	0.0955	0.238	CbGbCtD
Amphetamine—SLC22A5—Nicotine—ulcerative colitis	0.0593	0.148	CbGbCtD
Amphetamine—CYP2A6—Nicotine—ulcerative colitis	0.0451	0.112	CbGbCtD
Amphetamine—CYP2A6—Prednisolone—ulcerative colitis	0.0297	0.074	CbGbCtD
Amphetamine—CYP2A6—Dexamethasone—ulcerative colitis	0.0175	0.0437	CbGbCtD
Amphetamine—CYP2D6—Nicotine—ulcerative colitis	0.0142	0.0354	CbGbCtD
Amphetamine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0127	0.0317	CbGbCtD
Amphetamine—CYP2D6—Dexamethasone—ulcerative colitis	0.0055	0.0137	CbGbCtD
Amphetamine—Pseudoephedrine—IL2—ulcerative colitis	0.000807	0.277	CrCbGaD
Amphetamine—Ephedrine—ADRB2—ulcerative colitis	0.000319	0.109	CrCbGaD
Amphetamine—Methamphetamine—SLC22A5—ulcerative colitis	0.000312	0.107	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB2—ulcerative colitis	0.000286	0.0982	CrCbGaD
Amphetamine—Pseudoephedrine—TNF—ulcerative colitis	0.000272	0.0936	CrCbGaD
Amphetamine—Nateglinide—PPARG—ulcerative colitis	0.000267	0.0919	CrCbGaD
Amphetamine—Pseudoephedrine—ADRB2—ulcerative colitis	0.000241	0.0829	CrCbGaD
Amphetamine—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.000216	0.00264	CcSEcCtD
Amphetamine—Infection—Azathioprine—ulcerative colitis	0.000216	0.00264	CcSEcCtD
Amphetamine—Palpitations—Mesalazine—ulcerative colitis	0.000214	0.00262	CcSEcCtD
Amphetamine—Dyspepsia—Budesonide—ulcerative colitis	0.000214	0.00262	CcSEcCtD
Amphetamine—Decreased appetite—Budesonide—ulcerative colitis	0.000212	0.00259	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00021	0.00257	CcSEcCtD
Amphetamine—Nausea—Nicotine—ulcerative colitis	0.00021	0.00257	CcSEcCtD
Amphetamine—Fatigue—Budesonide—ulcerative colitis	0.00021	0.00256	CcSEcCtD
Amphetamine—Affect lability—Prednisone—ulcerative colitis	0.00021	0.00256	CcSEcCtD
Amphetamine—Hypertension—Mesalazine—ulcerative colitis	0.00021	0.00256	CcSEcCtD
Amphetamine—Constipation—Budesonide—ulcerative colitis	0.000208	0.00254	CcSEcCtD
Amphetamine—Psychotic disorder—Prednisone—ulcerative colitis	0.000208	0.00254	CcSEcCtD
Amphetamine—Chest pain—Mesalazine—ulcerative colitis	0.000207	0.00252	CcSEcCtD
Amphetamine—Anxiety—Mesalazine—ulcerative colitis	0.000206	0.00251	CcSEcCtD
Amphetamine—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.000205	0.0025	CcSEcCtD
Amphetamine—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.000205	0.0025	CcSEcCtD
Amphetamine—Myocardial infarction—Triamcinolone—ulcerative colitis	0.000204	0.00249	CcSEcCtD
Amphetamine—Irritability—Prednisone—ulcerative colitis	0.000204	0.00249	CcSEcCtD
Amphetamine—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.000203	0.00248	CcSEcCtD
Amphetamine—Dry mouth—Mesalazine—ulcerative colitis	0.000202	0.00247	CcSEcCtD
Amphetamine—Mood swings—Prednisone—ulcerative colitis	0.000202	0.00247	CcSEcCtD
Amphetamine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000199	0.00243	CcSEcCtD
Amphetamine—Sweating—Methylprednisolone—ulcerative colitis	0.000199	0.00243	CcSEcCtD
Amphetamine—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000198	0.00242	CcSEcCtD
Amphetamine—Nateglinide—PTGS1—ulcerative colitis	0.000197	0.0679	CrCbGaD
Amphetamine—Infection—Mesalazine—ulcerative colitis	0.000197	0.0024	CcSEcCtD
Amphetamine—Urticaria—Budesonide—ulcerative colitis	0.000193	0.00236	CcSEcCtD
Amphetamine—Tachycardia—Mesalazine—ulcerative colitis	0.000193	0.00236	CcSEcCtD
Amphetamine—Abdominal pain—Budesonide—ulcerative colitis	0.000193	0.00235	CcSEcCtD
Amphetamine—Body temperature increased—Budesonide—ulcerative colitis	0.000193	0.00235	CcSEcCtD
Amphetamine—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000191	0.00234	CcSEcCtD
Amphetamine—Weight decreased—Dexamethasone—ulcerative colitis	0.000191	0.00234	CcSEcCtD
Amphetamine—Weight decreased—Betamethasone—ulcerative colitis	0.000191	0.00234	CcSEcCtD
Amphetamine—Anorexia—Mesalazine—ulcerative colitis	0.000189	0.00231	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000188	0.00229	CcSEcCtD
Amphetamine—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000186	0.00227	CcSEcCtD
Amphetamine—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000186	0.00227	CcSEcCtD
Amphetamine—Myocardial infarction—Dexamethasone—ulcerative colitis	0.000185	0.00226	CcSEcCtD
Amphetamine—Myocardial infarction—Betamethasone—ulcerative colitis	0.000185	0.00226	CcSEcCtD
Amphetamine—Hypersensitivity—Budesonide—ulcerative colitis	0.000179	0.00219	CcSEcCtD
Amphetamine—Insomnia—Mesalazine—ulcerative colitis	0.000179	0.00219	CcSEcCtD
Amphetamine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000178	0.00217	CcSEcCtD
Amphetamine—Dyspnoea—Mesalazine—ulcerative colitis	0.000177	0.00216	CcSEcCtD
Amphetamine—Somnolence—Mesalazine—ulcerative colitis	0.000176	0.00215	CcSEcCtD
Amphetamine—Asthenia—Budesonide—ulcerative colitis	0.000175	0.00213	CcSEcCtD
Amphetamine—Dyspepsia—Mesalazine—ulcerative colitis	0.000174	0.00213	CcSEcCtD
Amphetamine—Decreased appetite—Mesalazine—ulcerative colitis	0.000172	0.0021	CcSEcCtD
Amphetamine—Abdominal pain—Azathioprine—ulcerative colitis	0.000172	0.0021	CcSEcCtD
Amphetamine—Body temperature increased—Azathioprine—ulcerative colitis	0.000172	0.0021	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000171	0.00209	CcSEcCtD
Amphetamine—Fatigue—Mesalazine—ulcerative colitis	0.000171	0.00209	CcSEcCtD
Amphetamine—Erectile dysfunction—Prednisone—ulcerative colitis	0.00017	0.00207	CcSEcCtD
Amphetamine—Constipation—Mesalazine—ulcerative colitis	0.000169	0.00207	CcSEcCtD
Amphetamine—Weight decreased—Prednisone—ulcerative colitis	0.000167	0.00204	CcSEcCtD
Amphetamine—Diarrhoea—Budesonide—ulcerative colitis	0.000167	0.00203	CcSEcCtD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000166	0.00283	CbGpPWpGaD
Amphetamine—Depression—Prednisone—ulcerative colitis	0.000164	0.002	CcSEcCtD
Amphetamine—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000162	0.00198	CcSEcCtD
Amphetamine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000162	0.00198	CcSEcCtD
Amphetamine—Angioedema—Prednisolone—ulcerative colitis	0.000161	0.00197	CcSEcCtD
Amphetamine—Myocardial infarction—Prednisone—ulcerative colitis	0.000161	0.00197	CcSEcCtD
Amphetamine—Dizziness—Budesonide—ulcerative colitis	0.000161	0.00197	CcSEcCtD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.00016	0.00274	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.00016	0.00274	CbGpPWpGaD
Amphetamine—Hypersensitivity—Azathioprine—ulcerative colitis	0.00016	0.00196	CcSEcCtD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000159	0.00272	CbGpPWpGaD
Amphetamine—Angioedema—Hydrocortisone—ulcerative colitis	0.000158	0.00193	CcSEcCtD
Amphetamine—Urticaria—Mesalazine—ulcerative colitis	0.000157	0.00192	CcSEcCtD
Amphetamine—Body temperature increased—Mesalazine—ulcerative colitis	0.000157	0.00191	CcSEcCtD
Amphetamine—Abdominal pain—Mesalazine—ulcerative colitis	0.000157	0.00191	CcSEcCtD
Amphetamine—SLC6A2—Monoamine Transport—IL1B—ulcerative colitis	0.000156	0.00267	CbGpPWpGaD
Amphetamine—Vomiting—Budesonide—ulcerative colitis	0.000155	0.00189	CcSEcCtD
Amphetamine—Rash—Budesonide—ulcerative colitis	0.000154	0.00188	CcSEcCtD
Amphetamine—Dermatitis—Budesonide—ulcerative colitis	0.000153	0.00187	CcSEcCtD
Amphetamine—Convulsion—Prednisolone—ulcerative colitis	0.000153	0.00187	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—GHRL—ulcerative colitis	0.000153	0.00261	CbGpPWpGaD
Amphetamine—Headache—Budesonide—ulcerative colitis	0.000153	0.00186	CcSEcCtD
Amphetamine—Hypertension—Prednisolone—ulcerative colitis	0.000153	0.00186	CcSEcCtD
Amphetamine—Convulsion—Hydrocortisone—ulcerative colitis	0.00015	0.00183	CcSEcCtD
Amphetamine—Hypertension—Hydrocortisone—ulcerative colitis	0.000149	0.00182	CcSEcCtD
Amphetamine—Diarrhoea—Azathioprine—ulcerative colitis	0.000149	0.00182	CcSEcCtD
Amphetamine—Angioedema—Triamcinolone—ulcerative colitis	0.000148	0.00181	CcSEcCtD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000148	0.00253	CbGpPWpGaD
Amphetamine—Angioedema—Methylprednisolone—ulcerative colitis	0.000148	0.00181	CcSEcCtD
Amphetamine—Anxiety—Hydrocortisone—ulcerative colitis	0.000146	0.00179	CcSEcCtD
Amphetamine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000146	0.00178	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000146	0.00249	CbGpPWpGaD
Amphetamine—Nausea—Budesonide—ulcerative colitis	0.000145	0.00177	CcSEcCtD
Amphetamine—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000144	0.00176	CcSEcCtD
Amphetamine—Dizziness—Azathioprine—ulcerative colitis	0.000144	0.00176	CcSEcCtD
Amphetamine—Asthenia—Mesalazine—ulcerative colitis	0.000142	0.00174	CcSEcCtD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000142	0.00242	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000142	0.00242	CbGpPWpGaD
Amphetamine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000141	0.00172	CcSEcCtD
Amphetamine—Convulsion—Triamcinolone—ulcerative colitis	0.000141	0.00172	CcSEcCtD
Amphetamine—Tachycardia—Prednisolone—ulcerative colitis	0.000141	0.00172	CcSEcCtD
Amphetamine—Convulsion—Methylprednisolone—ulcerative colitis	0.00014	0.00172	CcSEcCtD
Amphetamine—Hypertension—Triamcinolone—ulcerative colitis	0.00014	0.00171	CcSEcCtD
Amphetamine—Hypertension—Methylprednisolone—ulcerative colitis	0.00014	0.00171	CcSEcCtD
Amphetamine—Infection—Hydrocortisone—ulcerative colitis	0.00014	0.00171	CcSEcCtD
Amphetamine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000139	0.0017	CcSEcCtD
Amphetamine—SLC6A3—Monoamine Transport—IL1B—ulcerative colitis	0.000139	0.00236	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000138	0.00236	CbGpPWpGaD
Amphetamine—Vomiting—Azathioprine—ulcerative colitis	0.000138	0.00169	CcSEcCtD
Amphetamine—Anxiety—Methylprednisolone—ulcerative colitis	0.000138	0.00168	CcSEcCtD
Amphetamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000137	0.00168	CcSEcCtD
Amphetamine—Rash—Azathioprine—ulcerative colitis	0.000137	0.00167	CcSEcCtD
Amphetamine—Dermatitis—Azathioprine—ulcerative colitis	0.000137	0.00167	CcSEcCtD
Amphetamine—Headache—Azathioprine—ulcerative colitis	0.000136	0.00166	CcSEcCtD
Amphetamine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000136	0.00166	CcSEcCtD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	0.000136	0.00231	CbGpPWpGaD
Amphetamine—Diarrhoea—Mesalazine—ulcerative colitis	0.000136	0.00165	CcSEcCtD
Amphetamine—Dry mouth—Triamcinolone—ulcerative colitis	0.000135	0.00165	CcSEcCtD
Amphetamine—Angioedema—Dexamethasone—ulcerative colitis	0.000135	0.00165	CcSEcCtD
Amphetamine—Angioedema—Betamethasone—ulcerative colitis	0.000135	0.00165	CcSEcCtD
Amphetamine—Anorexia—Hydrocortisone—ulcerative colitis	0.000134	0.00164	CcSEcCtD
Amphetamine—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000133	0.00162	CcSEcCtD
Amphetamine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000132	0.00162	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000132	0.00226	CbGpPWpGaD
Amphetamine—SLC6A4—Monoamine Transport—TNF—ulcerative colitis	0.000132	0.00225	CbGpPWpGaD
Amphetamine—Infection—Triamcinolone—ulcerative colitis	0.000132	0.00161	CcSEcCtD
Amphetamine—Infection—Methylprednisolone—ulcerative colitis	0.000131	0.00161	CcSEcCtD
Amphetamine—Dizziness—Mesalazine—ulcerative colitis	0.000131	0.0016	CcSEcCtD
Amphetamine—Insomnia—Prednisolone—ulcerative colitis	0.00013	0.00159	CcSEcCtD
Amphetamine—Tachycardia—Triamcinolone—ulcerative colitis	0.000129	0.00158	CcSEcCtD
Amphetamine—Nausea—Azathioprine—ulcerative colitis	0.000129	0.00158	CcSEcCtD
Amphetamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000129	0.00158	CcSEcCtD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000128	0.00219	CbGpPWpGaD
Amphetamine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000128	0.00157	CcSEcCtD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000128	0.00218	CbGpPWpGaD
Amphetamine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000128	0.00156	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000128	0.00218	CbGpPWpGaD
Amphetamine—Convulsion—Betamethasone—ulcerative colitis	0.000128	0.00156	CcSEcCtD
Amphetamine—Convulsion—Dexamethasone—ulcerative colitis	0.000128	0.00156	CcSEcCtD
Amphetamine—Insomnia—Hydrocortisone—ulcerative colitis	0.000127	0.00156	CcSEcCtD
Amphetamine—Hypertension—Dexamethasone—ulcerative colitis	0.000127	0.00155	CcSEcCtD
Amphetamine—Hypertension—Betamethasone—ulcerative colitis	0.000127	0.00155	CcSEcCtD
Amphetamine—TAAR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000127	0.00216	CbGpPWpGaD
Amphetamine—Vomiting—Mesalazine—ulcerative colitis	0.000126	0.00154	CcSEcCtD
Amphetamine—Anxiety—Dexamethasone—ulcerative colitis	0.000125	0.00153	CcSEcCtD
Amphetamine—Anxiety—Betamethasone—ulcerative colitis	0.000125	0.00153	CcSEcCtD
Amphetamine—Rash—Mesalazine—ulcerative colitis	0.000125	0.00153	CcSEcCtD
Amphetamine—Dermatitis—Mesalazine—ulcerative colitis	0.000125	0.00152	CcSEcCtD
Amphetamine—Headache—Mesalazine—ulcerative colitis	0.000124	0.00152	CcSEcCtD
Amphetamine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000124	0.00151	CcSEcCtD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000123	0.00209	CbGpPWpGaD
Amphetamine—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000122	0.0015	CcSEcCtD
Amphetamine—SLC6A3—Dopaminergic Neurogenesis—STAT3—ulcerative colitis	0.000122	0.00209	CbGpPWpGaD
Amphetamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000122	0.00148	CcSEcCtD
Amphetamine—Fatigue—Hydrocortisone—ulcerative colitis	0.000121	0.00148	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000121	0.00207	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000121	0.00207	CbGpPWpGaD
Amphetamine—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00012	0.00147	CcSEcCtD
Amphetamine—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00012	0.00147	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.00012	0.00205	CbGpPWpGaD
Amphetamine—Insomnia—Triamcinolone—ulcerative colitis	0.00012	0.00146	CcSEcCtD
Amphetamine—Insomnia—Methylprednisolone—ulcerative colitis	0.00012	0.00146	CcSEcCtD
Amphetamine—Infection—Dexamethasone—ulcerative colitis	0.00012	0.00146	CcSEcCtD
Amphetamine—Infection—Betamethasone—ulcerative colitis	0.00012	0.00146	CcSEcCtD
Amphetamine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000118	0.00144	CcSEcCtD
Amphetamine—Agitation—Prednisone—ulcerative colitis	0.000118	0.00144	CcSEcCtD
Amphetamine—Nausea—Mesalazine—ulcerative colitis	0.000118	0.00144	CcSEcCtD
Amphetamine—Tachycardia—Betamethasone—ulcerative colitis	0.000117	0.00143	CcSEcCtD
Amphetamine—Tachycardia—Dexamethasone—ulcerative colitis	0.000117	0.00143	CcSEcCtD
Amphetamine—Angioedema—Prednisone—ulcerative colitis	0.000117	0.00143	CcSEcCtD
Amphetamine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000117	0.00143	CcSEcCtD
Amphetamine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000116	0.00142	CcSEcCtD
Amphetamine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000116	0.00142	CcSEcCtD
Amphetamine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000116	0.00142	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CCL20—ulcerative colitis	0.000116	0.00198	CbGpPWpGaD
Amphetamine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000115	0.00141	CcSEcCtD
Amphetamine—Anorexia—Betamethasone—ulcerative colitis	0.000115	0.0014	CcSEcCtD
Amphetamine—Anorexia—Dexamethasone—ulcerative colitis	0.000115	0.0014	CcSEcCtD
Amphetamine—Urticaria—Prednisolone—ulcerative colitis	0.000115	0.0014	CcSEcCtD
Amphetamine—Fatigue—Triamcinolone—ulcerative colitis	0.000114	0.0014	CcSEcCtD
Amphetamine—Fatigue—Methylprednisolone—ulcerative colitis	0.000114	0.00139	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000114	0.00194	CbGpPWpGaD
Amphetamine—SLC6A2—Monoamine Transport—TNF—ulcerative colitis	0.000114	0.00194	CbGpPWpGaD
Amphetamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—ulcerative colitis	0.000113	0.00193	CbGpPWpGaD
Amphetamine—Urticaria—Hydrocortisone—ulcerative colitis	0.000112	0.00137	CcSEcCtD
Amphetamine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000111	0.00136	CcSEcCtD
Amphetamine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000111	0.00136	CcSEcCtD
Amphetamine—Convulsion—Prednisone—ulcerative colitis	0.000111	0.00136	CcSEcCtD
Amphetamine—Hypertension—Prednisone—ulcerative colitis	0.000111	0.00135	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—GNA12—ulcerative colitis	0.000109	0.00186	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—GHRL—ulcerative colitis	0.000109	0.00186	CbGpPWpGaD
Amphetamine—Anxiety—Prednisone—ulcerative colitis	0.000109	0.00133	CcSEcCtD
Amphetamine—Insomnia—Betamethasone—ulcerative colitis	0.000109	0.00133	CcSEcCtD
Amphetamine—Insomnia—Dexamethasone—ulcerative colitis	0.000109	0.00133	CcSEcCtD
Amphetamine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000108	0.00132	CcSEcCtD
Amphetamine—Selegiline—ABCB1—ulcerative colitis	0.000107	0.0369	CrCbGaD
Amphetamine—TAAR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000107	0.00183	CbGpPWpGaD
Amphetamine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000106	0.0013	CcSEcCtD
Amphetamine—Dyspepsia—Betamethasone—ulcerative colitis	0.000106	0.00129	CcSEcCtD
Amphetamine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000106	0.00129	CcSEcCtD
Amphetamine—Urticaria—Triamcinolone—ulcerative colitis	0.000105	0.00129	CcSEcCtD
Amphetamine—Urticaria—Methylprednisolone—ulcerative colitis	0.000105	0.00128	CcSEcCtD
Amphetamine—Body temperature increased—Triamcinolone—ulcerative colitis	0.000105	0.00128	CcSEcCtD
Amphetamine—Anaphylactic shock—Prednisone—ulcerative colitis	0.000105	0.00128	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000105	0.00179	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000105	0.00179	CbGpPWpGaD
Amphetamine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000105	0.00128	CcSEcCtD
Amphetamine—Decreased appetite—Betamethasone—ulcerative colitis	0.000105	0.00128	CcSEcCtD
Amphetamine—Decreased appetite—Dexamethasone—ulcerative colitis	0.000105	0.00128	CcSEcCtD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000104	0.00178	CbGpPWpGaD
Amphetamine—Infection—Prednisone—ulcerative colitis	0.000104	0.00127	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000104	0.00127	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000104	0.00127	CcSEcCtD
Amphetamine—SLC18A2—Neuronal System—CALM3—ulcerative colitis	0.000104	0.00177	CbGpPWpGaD
Amphetamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000104	0.00127	CcSEcCtD
Amphetamine—Fatigue—Betamethasone—ulcerative colitis	0.000104	0.00127	CcSEcCtD
Amphetamine—Fatigue—Dexamethasone—ulcerative colitis	0.000104	0.00127	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000104	0.00177	CbGpPWpGaD
Amphetamine—Tachycardia—Prednisone—ulcerative colitis	0.000102	0.00125	CcSEcCtD
Amphetamine—Hyperhidrosis—Prednisone—ulcerative colitis	0.000101	0.00124	CcSEcCtD
Amphetamine—Asthenia—Hydrocortisone—ulcerative colitis	0.000101	0.00123	CcSEcCtD
Amphetamine—Nateglinide—ALB—ulcerative colitis	0.000101	0.0346	CrCbGaD
Amphetamine—SLC6A3—Monoamine Transport—TNF—ulcerative colitis	0.000101	0.00172	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	9.99e-05	0.0017	CbGpPWpGaD
Amphetamine—Anorexia—Prednisone—ulcerative colitis	9.99e-05	0.00122	CcSEcCtD
Amphetamine—DRD2—G alpha (i) signalling events—CXCR1—ulcerative colitis	9.93e-05	0.00169	CbGpPWpGaD
Amphetamine—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.84e-05	0.0012	CcSEcCtD
Amphetamine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.84e-05	0.0012	CcSEcCtD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	9.83e-05	0.00168	CbGpPWpGaD
Amphetamine—Hypersensitivity—Triamcinolone—ulcerative colitis	9.77e-05	0.00119	CcSEcCtD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL10—ulcerative colitis	9.77e-05	0.00167	CbGpPWpGaD
Amphetamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.75e-05	0.00119	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CCR6—ulcerative colitis	9.73e-05	0.00166	CbGpPWpGaD
Amphetamine—Diarrhoea—Hydrocortisone—ulcerative colitis	9.64e-05	0.00118	CcSEcCtD
Amphetamine—Urticaria—Dexamethasone—ulcerative colitis	9.56e-05	0.00117	CcSEcCtD
Amphetamine—Urticaria—Betamethasone—ulcerative colitis	9.56e-05	0.00117	CcSEcCtD
Amphetamine—Dizziness—Prednisolone—ulcerative colitis	9.54e-05	0.00116	CcSEcCtD
Amphetamine—Asthenia—Triamcinolone—ulcerative colitis	9.52e-05	0.00116	CcSEcCtD
Amphetamine—Abdominal pain—Dexamethasone—ulcerative colitis	9.51e-05	0.00116	CcSEcCtD
Amphetamine—Body temperature increased—Betamethasone—ulcerative colitis	9.51e-05	0.00116	CcSEcCtD
Amphetamine—Abdominal pain—Betamethasone—ulcerative colitis	9.51e-05	0.00116	CcSEcCtD
Amphetamine—Body temperature increased—Dexamethasone—ulcerative colitis	9.51e-05	0.00116	CcSEcCtD
Amphetamine—Asthenia—Methylprednisolone—ulcerative colitis	9.49e-05	0.00116	CcSEcCtD
Amphetamine—TAAR1—Signaling Pathways—SEL1L—ulcerative colitis	9.49e-05	0.00162	CbGpPWpGaD
Amphetamine—Insomnia—Prednisone—ulcerative colitis	9.48e-05	0.00116	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—PTGER4—ulcerative colitis	9.44e-05	0.00161	CbGpPWpGaD
Amphetamine—Dizziness—Hydrocortisone—ulcerative colitis	9.31e-05	0.00114	CcSEcCtD
Amphetamine—Dyspepsia—Prednisone—ulcerative colitis	9.22e-05	0.00113	CcSEcCtD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	9.21e-05	0.00157	CbGpPWpGaD
Amphetamine—Decreased appetite—Prednisone—ulcerative colitis	9.11e-05	0.00111	CcSEcCtD
Amphetamine—Rash—Prednisolone—ulcerative colitis	9.09e-05	0.00111	CcSEcCtD
Amphetamine—Dermatitis—Prednisolone—ulcerative colitis	9.08e-05	0.00111	CcSEcCtD
Amphetamine—Diarrhoea—Methylprednisolone—ulcerative colitis	9.05e-05	0.00111	CcSEcCtD
Amphetamine—Fatigue—Prednisone—ulcerative colitis	9.04e-05	0.0011	CcSEcCtD
Amphetamine—Headache—Prednisolone—ulcerative colitis	9.03e-05	0.0011	CcSEcCtD
Amphetamine—Constipation—Prednisone—ulcerative colitis	8.96e-05	0.00109	CcSEcCtD
Amphetamine—Vomiting—Hydrocortisone—ulcerative colitis	8.96e-05	0.00109	CcSEcCtD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.93e-05	0.00152	CbGpPWpGaD
Amphetamine—Rash—Hydrocortisone—ulcerative colitis	8.88e-05	0.00108	CcSEcCtD
Amphetamine—Dermatitis—Hydrocortisone—ulcerative colitis	8.87e-05	0.00108	CcSEcCtD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	8.85e-05	0.00151	CbGpPWpGaD
Amphetamine—Headache—Hydrocortisone—ulcerative colitis	8.82e-05	0.00108	CcSEcCtD
Amphetamine—Dizziness—Triamcinolone—ulcerative colitis	8.77e-05	0.00107	CcSEcCtD
Amphetamine—Dizziness—Methylprednisolone—ulcerative colitis	8.75e-05	0.00107	CcSEcCtD
Amphetamine—DRD2—G alpha (i) signalling events—CCL20—ulcerative colitis	8.72e-05	0.00149	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—GHRL—ulcerative colitis	8.64e-05	0.00147	CbGpPWpGaD
Amphetamine—Asthenia—Dexamethasone—ulcerative colitis	8.63e-05	0.00105	CcSEcCtD
Amphetamine—Asthenia—Betamethasone—ulcerative colitis	8.63e-05	0.00105	CcSEcCtD
Amphetamine—Gastrointestinal pain—Prednisone—ulcerative colitis	8.57e-05	0.00105	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—PTGER4—ulcerative colitis	8.57e-05	0.00146	CbGpPWpGaD
Amphetamine—Nausea—Prednisolone—ulcerative colitis	8.57e-05	0.00105	CcSEcCtD
Amphetamine—CYP2A6—Biological oxidations—PTGS1—ulcerative colitis	8.46e-05	0.00144	CbGpPWpGaD
Amphetamine—Vomiting—Triamcinolone—ulcerative colitis	8.43e-05	0.00103	CcSEcCtD
Amphetamine—Vomiting—Methylprednisolone—ulcerative colitis	8.41e-05	0.00103	CcSEcCtD
Amphetamine—Nausea—Hydrocortisone—ulcerative colitis	8.37e-05	0.00102	CcSEcCtD
Amphetamine—Rash—Triamcinolone—ulcerative colitis	8.36e-05	0.00102	CcSEcCtD
Amphetamine—Dermatitis—Triamcinolone—ulcerative colitis	8.35e-05	0.00102	CcSEcCtD
Amphetamine—Rash—Methylprednisolone—ulcerative colitis	8.34e-05	0.00102	CcSEcCtD
Amphetamine—Dermatitis—Methylprednisolone—ulcerative colitis	8.34e-05	0.00102	CcSEcCtD
Amphetamine—Urticaria—Prednisone—ulcerative colitis	8.33e-05	0.00102	CcSEcCtD
Amphetamine—Headache—Triamcinolone—ulcerative colitis	8.31e-05	0.00101	CcSEcCtD
Amphetamine—Headache—Methylprednisolone—ulcerative colitis	8.29e-05	0.00101	CcSEcCtD
Amphetamine—Abdominal pain—Prednisone—ulcerative colitis	8.28e-05	0.00101	CcSEcCtD
Amphetamine—Body temperature increased—Prednisone—ulcerative colitis	8.28e-05	0.00101	CcSEcCtD
Amphetamine—Diarrhoea—Dexamethasone—ulcerative colitis	8.23e-05	0.00101	CcSEcCtD
Amphetamine—Diarrhoea—Betamethasone—ulcerative colitis	8.23e-05	0.00101	CcSEcCtD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	8.15e-05	0.00139	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	8.15e-05	0.00139	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—CALM3—ulcerative colitis	8.08e-05	0.00138	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	8.02e-05	0.00137	CbGpPWpGaD
Amphetamine—Dizziness—Dexamethasone—ulcerative colitis	7.96e-05	0.000972	CcSEcCtD
Amphetamine—Dizziness—Betamethasone—ulcerative colitis	7.96e-05	0.000972	CcSEcCtD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	7.89e-05	0.00135	CbGpPWpGaD
Amphetamine—Nausea—Triamcinolone—ulcerative colitis	7.88e-05	0.000962	CcSEcCtD
Amphetamine—Nausea—Methylprednisolone—ulcerative colitis	7.86e-05	0.00096	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—GHRL—ulcerative colitis	7.84e-05	0.00134	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCR1—ulcerative colitis	7.81e-05	0.00133	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCR2—ulcerative colitis	7.77e-05	0.00133	CbGpPWpGaD
Amphetamine—Hypersensitivity—Prednisone—ulcerative colitis	7.72e-05	0.000943	CcSEcCtD
Amphetamine—Vomiting—Betamethasone—ulcerative colitis	7.65e-05	0.000934	CcSEcCtD
Amphetamine—Vomiting—Dexamethasone—ulcerative colitis	7.65e-05	0.000934	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CALM3—ulcerative colitis	7.6e-05	0.0013	CbGpPWpGaD
Amphetamine—Rash—Dexamethasone—ulcerative colitis	7.59e-05	0.000927	CcSEcCtD
Amphetamine—Rash—Betamethasone—ulcerative colitis	7.59e-05	0.000927	CcSEcCtD
Amphetamine—Dermatitis—Betamethasone—ulcerative colitis	7.58e-05	0.000926	CcSEcCtD
Amphetamine—Dermatitis—Dexamethasone—ulcerative colitis	7.58e-05	0.000926	CcSEcCtD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.54e-05	0.00129	CbGpPWpGaD
Amphetamine—Headache—Dexamethasone—ulcerative colitis	7.54e-05	0.000921	CcSEcCtD
Amphetamine—Headache—Betamethasone—ulcerative colitis	7.54e-05	0.000921	CcSEcCtD
Amphetamine—SLC18A2—Neuronal System—ADCY5—ulcerative colitis	7.53e-05	0.00129	CbGpPWpGaD
Amphetamine—Asthenia—Prednisone—ulcerative colitis	7.52e-05	0.000918	CcSEcCtD
Amphetamine—DRD2—G alpha (i) signalling events—CCR6—ulcerative colitis	7.3e-05	0.00125	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—TP53—ulcerative colitis	7.23e-05	0.00123	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	7.22e-05	0.00123	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	7.22e-05	0.00123	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	7.21e-05	0.00123	CbGpPWpGaD
Amphetamine—Diarrhoea—Prednisone—ulcerative colitis	7.17e-05	0.000876	CcSEcCtD
Amphetamine—TAAR1—GPCR downstream signaling—ADRB2—ulcerative colitis	7.15e-05	0.00122	CbGpPWpGaD
Amphetamine—Nausea—Dexamethasone—ulcerative colitis	7.15e-05	0.000873	CcSEcCtD
Amphetamine—Nausea—Betamethasone—ulcerative colitis	7.15e-05	0.000873	CcSEcCtD
Amphetamine—MAOB—Metabolism—CHP1—ulcerative colitis	7.11e-05	0.00121	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	6.93e-05	0.00118	CbGpPWpGaD
Amphetamine—Dizziness—Prednisone—ulcerative colitis	6.93e-05	0.000846	CcSEcCtD
Amphetamine—TAAR1—Signaling Pathways—CCL20—ulcerative colitis	6.86e-05	0.00117	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	6.78e-05	0.00116	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—GHRL—ulcerative colitis	6.67e-05	0.00114	CbGpPWpGaD
Amphetamine—Vomiting—Prednisone—ulcerative colitis	6.66e-05	0.000814	CcSEcCtD
Amphetamine—Rash—Prednisone—ulcerative colitis	6.61e-05	0.000807	CcSEcCtD
Amphetamine—Dermatitis—Prednisone—ulcerative colitis	6.6e-05	0.000806	CcSEcCtD
Amphetamine—Headache—Prednisone—ulcerative colitis	6.57e-05	0.000802	CcSEcCtD
Amphetamine—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	6.55e-05	0.00112	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	6.52e-05	0.00111	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	6.5e-05	0.00111	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—ADRB2—ulcerative colitis	6.49e-05	0.00111	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GNA12—ulcerative colitis	6.45e-05	0.0011	CbGpPWpGaD
Amphetamine—Nausea—Prednisone—ulcerative colitis	6.22e-05	0.00076	CcSEcCtD
Amphetamine—SLC6A3—Neuronal System—CALM3—ulcerative colitis	6.19e-05	0.00106	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	6.18e-05	0.00105	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—DLD—ulcerative colitis	6.14e-05	0.00105	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCR2—ulcerative colitis	6.11e-05	0.00104	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CXCL8—ulcerative colitis	6.11e-05	0.00104	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—ADCY5—ulcerative colitis	6.07e-05	0.00104	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CHP1—ulcerative colitis	6.02e-05	0.00103	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCR1—ulcerative colitis	6.01e-05	0.00103	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	5.97e-05	0.00102	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	5.86e-05	0.001	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	5.81e-05	0.000991	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCR6—ulcerative colitis	5.75e-05	0.000981	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—PPARG—ulcerative colitis	5.72e-05	0.000975	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—ADCY5—ulcerative colitis	5.51e-05	0.00094	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAML2—ulcerative colitis	5.45e-05	0.00093	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	5.35e-05	0.000912	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	5.34e-05	0.000911	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL20—ulcerative colitis	5.28e-05	0.0009	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—DLD—ulcerative colitis	5.2e-05	0.000886	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	5.12e-05	0.000874	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.11e-05	0.000872	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.08e-05	0.000866	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTGER4—ulcerative colitis	5.06e-05	0.000864	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	4.78e-05	0.000815	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	4.74e-05	0.000809	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCR2—ulcerative colitis	4.7e-05	0.000803	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	4.68e-05	0.000799	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GHRL—ulcerative colitis	4.63e-05	0.000791	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	4.62e-05	0.000789	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—ALB—ulcerative colitis	4.61e-05	0.000786	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	4.52e-05	0.000772	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.5e-05	0.000767	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—ADCY5—ulcerative colitis	4.49e-05	0.000766	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CALM3—ulcerative colitis	4.49e-05	0.000766	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCR6—ulcerative colitis	4.42e-05	0.000755	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RIPK2—ulcerative colitis	4.42e-05	0.000754	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.34e-05	0.000741	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—TGFB1—ulcerative colitis	4.2e-05	0.000716	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—ADCY5—ulcerative colitis	4.14e-05	0.000706	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.05e-05	0.000691	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PTGER4—ulcerative colitis	3.89e-05	0.000664	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	3.88e-05	0.000661	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ADRB2—ulcerative colitis	3.84e-05	0.000654	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—JAK2—ulcerative colitis	3.78e-05	0.000646	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.75e-05	0.000641	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.74e-05	0.000639	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—ulcerative colitis	3.72e-05	0.000634	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—TGFB1—ulcerative colitis	3.61e-05	0.000616	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.6e-05	0.000614	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GHRL—ulcerative colitis	3.56e-05	0.000608	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.5e-05	0.000598	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PPARG—ulcerative colitis	3.5e-05	0.000596	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.49e-05	0.000596	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CHP1—ulcerative colitis	3.47e-05	0.000591	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL8—ulcerative colitis	3.45e-05	0.000589	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—JAK2—ulcerative colitis	3.44e-05	0.000586	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCR1—ulcerative colitis	3.4e-05	0.00058	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—IL2—ulcerative colitis	3.3e-05	0.000563	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ADCY5—ulcerative colitis	3.26e-05	0.000555	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—ulcerative colitis	3.2e-05	0.000546	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.19e-05	0.000544	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL8—ulcerative colitis	3.14e-05	0.000535	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCR1—ulcerative colitis	3.08e-05	0.000526	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3e-05	0.000512	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL2—ulcerative colitis	3e-05	0.000511	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DLD—ulcerative colitis	2.99e-05	0.00051	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL20—ulcerative colitis	2.98e-05	0.000509	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS1—ulcerative colitis	2.97e-05	0.000506	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—ADRB2—ulcerative colitis	2.95e-05	0.000503	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.92e-05	0.000498	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GNA12—ulcerative colitis	2.8e-05	0.000478	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.73e-05	0.000465	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.72e-05	0.000463	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL20—ulcerative colitis	2.71e-05	0.000462	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—ulcerative colitis	2.68e-05	0.000457	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CALM3—ulcerative colitis	2.67e-05	0.000456	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—ulcerative colitis	2.67e-05	0.000456	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCR2—ulcerative colitis	2.66e-05	0.000454	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.59e-05	0.000442	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GNA12—ulcerative colitis	2.55e-05	0.000434	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS1—ulcerative colitis	2.51e-05	0.000429	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR6—ulcerative colitis	2.5e-05	0.000426	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—ulcerative colitis	2.45e-05	0.000418	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.41e-05	0.000412	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCR2—ulcerative colitis	2.41e-05	0.000412	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL8—ulcerative colitis	2.35e-05	0.000402	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.35e-05	0.000401	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.34e-05	0.000399	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR6—ulcerative colitis	2.27e-05	0.000387	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CALM3—ulcerative colitis	2.26e-05	0.000386	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SEL1L—ulcerative colitis	2.21e-05	0.000378	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTGER4—ulcerative colitis	2.2e-05	0.000375	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCB1—ulcerative colitis	2.08e-05	0.000355	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—JAK2—ulcerative colitis	2.03e-05	0.000346	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GHRL—ulcerative colitis	2.01e-05	0.000344	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTGER4—ulcerative colitis	2e-05	0.000341	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RELA—ulcerative colitis	1.97e-05	0.000335	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.94e-05	0.000332	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADCY5—ulcerative colitis	1.94e-05	0.000331	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.87e-05	0.000319	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL8—ulcerative colitis	1.85e-05	0.000316	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GHRL—ulcerative colitis	1.83e-05	0.000312	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.83e-05	0.000312	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR1—ulcerative colitis	1.82e-05	0.000311	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALM3—ulcerative colitis	1.77e-05	0.000302	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL2—ulcerative colitis	1.77e-05	0.000302	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—ulcerative colitis	1.76e-05	0.000301	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCB1—ulcerative colitis	1.76e-05	0.0003	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DLD—ulcerative colitis	1.68e-05	0.000286	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—ulcerative colitis	1.68e-05	0.000286	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADRB2—ulcerative colitis	1.67e-05	0.000285	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NFKB1—ulcerative colitis	1.66e-05	0.000283	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADCY5—ulcerative colitis	1.64e-05	0.00028	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—ulcerative colitis	1.64e-05	0.000279	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.62e-05	0.000276	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL20—ulcerative colitis	1.6e-05	0.000273	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADRB2—ulcerative colitis	1.51e-05	0.000258	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNA12—ulcerative colitis	1.5e-05	0.000257	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—ulcerative colitis	1.5e-05	0.000256	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—STAT3—ulcerative colitis	1.49e-05	0.000254	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS1—ulcerative colitis	1.45e-05	0.000247	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—ulcerative colitis	1.45e-05	0.000247	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR2—ulcerative colitis	1.43e-05	0.000243	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL8—ulcerative colitis	1.43e-05	0.000243	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.42e-05	0.000241	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—ulcerative colitis	1.38e-05	0.000236	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR6—ulcerative colitis	1.34e-05	0.000229	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CALM3—ulcerative colitis	1.3e-05	0.000222	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—ulcerative colitis	1.3e-05	0.000222	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADCY5—ulcerative colitis	1.29e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAML2—ulcerative colitis	1.27e-05	0.000217	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—ulcerative colitis	1.22e-05	0.000209	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTGER4—ulcerative colitis	1.18e-05	0.000201	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—ulcerative colitis	1.14e-05	0.000194	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—ulcerative colitis	1.14e-05	0.000194	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—ulcerative colitis	1.1e-05	0.000188	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GHRL—ulcerative colitis	1.08e-05	0.000184	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALM3—ulcerative colitis	1.05e-05	0.000179	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—ulcerative colitis	1.04e-05	0.000178	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RIPK2—ulcerative colitis	1.03e-05	0.000176	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCB1—ulcerative colitis	1.01e-05	0.000173	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—ulcerative colitis	9.62e-06	0.000164	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADCY5—ulcerative colitis	9.45e-06	0.000161	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB2—ulcerative colitis	8.95e-06	0.000153	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—JAK2—ulcerative colitis	8.82e-06	0.000151	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	8.11e-06	0.000138	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	8.05e-06	0.000137	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	8.01e-06	0.000137	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	7.7e-06	0.000131	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	7.59e-06	0.00013	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	7.31e-06	0.000125	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CALM3—ulcerative colitis	7.3e-06	0.000125	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—ulcerative colitis	7.04e-06	0.00012	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2—ulcerative colitis	6.99e-06	0.000119	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—ulcerative colitis	6.33e-06	0.000108	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	5.68e-06	9.69e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—ulcerative colitis	5.54e-06	9.45e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	5.3e-06	9.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAK2—ulcerative colitis	4.73e-06	8.08e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RELA—ulcerative colitis	4.58e-06	7.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	4.32e-06	7.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2—ulcerative colitis	4.13e-06	7.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—ulcerative colitis	4.11e-06	7.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.95e-06	6.74e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—ulcerative colitis	3.91e-06	6.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	3.87e-06	6.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—ulcerative colitis	3.55e-06	6.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—ulcerative colitis	3.47e-06	5.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	3.22e-06	5.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	3.11e-06	5.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—ulcerative colitis	2.65e-06	4.52e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—ulcerative colitis	2.43e-06	4.14e-05	CbGpPWpGaD
